CONMED Total Long Term Liabilities 2010-2024 | CNMD

CONMED total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
CONMED Annual Total Long Term Liabilities
(Millions of US $)
2023 $1,155
2022 $1,255
2021 $784
2020 $852
2019 $877
2018 $546
2017 $577
2016 $634
2015 $397
2014 $401
2013 $373
2012 $347
2011 $231
2010 $219
2009 $303
CONMED Quarterly Total Long Term Liabilities
(Millions of US $)
2024-06-30 $1,137
2024-03-31 $1,163
2023-12-31 $1,155
2023-09-30 $1,153
2023-06-30 $1,189
2023-03-31 $1,247
2022-12-31 $1,255
2022-09-30 $1,367
2022-06-30 $1,198
2022-03-31 $809
2021-12-31 $784
2021-09-30 $815
2021-06-30 $819
2021-03-31 $839
2020-12-31 $852
2020-09-30 $881
2020-06-30 $898
2020-03-31 $889
2019-12-31 $877
2019-09-30 $897
2019-06-30 $907
2019-03-31 $917
2018-12-31 $546
2018-09-30 $545
2018-06-30 $539
2018-03-31 $548
2017-12-31 $577
2017-09-30 $632
2017-06-30 $623
2017-03-31 $627
2016-12-31 $634
2016-09-30 $634
2016-06-30 $653
2016-03-31 $657
2015-12-31 $397
2015-09-30 $405
2015-06-30 $401
2015-03-31 $400
2014-12-31 $401
2014-09-30 $395
2014-06-30 $391
2014-03-31 $387
2013-12-31 $373
2013-09-30 $391
2013-06-30 $399
2013-03-31 $388
2012-12-31 $347
2012-09-30 $361
2012-06-30 $333
2012-03-31 $324
2011-12-31 $231
2011-09-30 $157
2011-06-30 $173
2011-03-31 $211
2010-12-31 $219
2010-09-30 $306
2010-06-30 $302
2010-03-31 $302
2009-12-31 $303
2009-09-30 $300
2009-06-30 $304
2009-03-31 $308
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.312B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.143B 21.32
Becton Dickinson (BDX) United States $67.812B 17.83
Cardinal Health (CAH) United States $29.438B 15.96
West Pharmaceutical Services (WST) United States $23.723B 48.46
Cooper (COO) United States $20.623B 29.35
Labcorp (LH) United States $20.401B 16.92
Align Technology (ALGN) United States $16.815B 32.18
Henry Schein (HSIC) United States $8.514B 16.22
Merit Medical Systems (MMSI) United States $6.067B 30.98
DENTSPLY SIRONA (XRAY) United States $3.508B 9.54
Patterson (PDCO) United States $1.855B 9.79
STAAR Surgical (STAA) United States $1.499B 55.31
Lifevantage (LFVN) United States $0.176B 23.40
Pro-Dex (PDEX) United States $0.154B 30.74